During the past decade, Center for Inherited Blood Disorders conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Inherited Blood Disorders" #1 collaborator was "LFB USA, Inc." with 1 trials as a collaborator, "Swedish Orphan Biovitrum" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Center for Inherited Blood Disorders" are "Hemophilia A With Inhibitor" (1 trials), "Hemophilia A With Inhibitors" (1 trials), "Hemophilia B With Inhibitor" (1 trials), "Hemophilic Arthropathy" (1 trials) and "Von Willebrand Diseases" (1 trials). Many other conditions were trialed in "Center for Inherited Blood Disorders" in a lesser frequency.

Most popular intervention types in "Center for Inherited Blood Disorders" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "TRM-201 (Rofecoxib)" (1 trials), "coagulation factor VIIa [recombinant]-jncw" (1 trials) and "rFVIIIFc" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Inherited Blood Disorders" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Center for Inherited Blood Disorders". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Center for Inherited Blood Disorders, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Center for Inherited Blood Disorders, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".